EBS: Pangali Forward P/E Emergent BioSolutions

Emergent BioSolutions (EBS) specializes in the development and supply of antiviral agents and vaccines. The price indicator on the Forward P/E chart is fixed at 5.80, which aligns with the plant modernization phase and a lack of new breakthroughs in the development pipeline. Simultaneously, rising geopolitical tensions provide the firm with multi-million dollar government contracts for the production of antidotes to ensure the security of allied states.

Pangali mangsa ngarep rega marang bathi: Emergent BioSolutions Inc (EBS) kanggo 04.07.2022 - 10.11.2026

Rincian analitis lan laporan data perusahaan Emergent Bio (EBS)

- rega saiki lan proyeksi nilai saham:

Kutipan saham Emergent BioSolutions Inc.|EBS - Bagan rega target

- informasi kapitalisasi pasar:

Kapitalisasi pasar Emergent BioSolutions Inc|EBS - Rega Tumbas Perusahaan

- informasi kapitalisasi buku:

Aset Bersih saben Siji Saham Emergent BioSolutions|EBS - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi marang Aset Bersih emergentbiosolutions.com|EBS - Total Aset Perusahaan

- rincian utang lan likuiditas:

Utang marang Ekuitas Emergent BioSolutions|EBS - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang modal Emergent BioSolutions|EBS - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Emergent BioSolutions Inc|EBS - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Emergent BioSolutions|Likuiditas cepet emergentbiosolutions.com

- indikator profitabilitas perusahaan lan kelipatan valuasi:

EBS - Bathi pungkasan|Proyeksi bathi mangsa ngarep Emergent BioSolutions|EBS - Rasio kapitalisasi marang bathi resik|Pangali Forward P/E Emergent Corp|EBS - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Emergent BioSolutions Inc|EBS - Bathi operasional sadurunge amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Emergent BioSolutions|EBS - Bathi saben saham sajrone patang kuartal pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan emergentbiosolutions.com|EBS - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Emergent BioSolutions

Analisis kabeh metrik perusahaan:EBS Emergent BioSolutions Inc.

Emergent BioSolutions is optimizing costs by outsourcing ingredient production and IT infrastructure. The forward P/E digitizes the efficiency of this model by comparing current market capitalization with projected net income. This metric measures market expectations regarding future earnings and business growth rates. A high ratio signals a premium valuation, while a low ratio indicates skepticism regarding profitability. Analyzing the company's future price-to-earnings ratio allows for an assessment of asset overvaluation risks.

Pesaing Emergent BioSolutions

Prakiraan rega marang bathi GILD (Gilead Sciences)|Rega marang bathi mangsa ngarep CDTX (Cidara Therapeutics)|Pangali Forward P/E NVAX (Novavax Corp)|Kapitalisasi marang proyeksi bathi CureVac Pharma (CVAC)|VALN - Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi VIR (vir.bio)|SIGA (SIGA Technologies) - Prakiraan rega marang bathi|Atea Pharma (AVIR) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Invivyd Inc|Enanta Pharmaceuticals, Inc (ENTA) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E INO|HLVX - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep Kalaris Therapeutics KLRS|DYAI - Prakiraan rega marang bathi|NanoViricides Corp - Pangali Forward P/E|Rasio prakiraan rega marang bathi Talphera Corporation|Cocrystal Pharma, Inc. (COCP) - Rega marang bathi mangsa ngarep|Traws Pharma - Pangali mangsa ngarep rega marang bathi|DWTX (Dogwood Therapeutics Inc.) - Pangali Forward P/E|QLGN - Pangali forward rega marang bathi|Pangali Forward P/E ALVR|VBIV - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep Virios Therapeutics, Inc. VIRI|VXRT: Rasio rega marang bathi mangsa ngarep